Flowers Foods enters its May 14 Q1 results with a striking divergence: short sellers have just made their most aggressive weekly move in months, yet options traders are betting heavily on the upside.
The short interest story is the dominant signal this week. Short interest jumped 11% in seven days to 13.1% of the free float — a sharp acceleration from the roughly 11.8% level that had been holding steady through most of April. That move came in a single burst around April 23-24, when estimated short shares leapt from 25 million to nearly 27.7 million. Days to cover now run at 6.1, placing FLO's short positioning in the 8th percentile of the market — meaning it is more heavily shorted than 92% of comparable names. The ORTEX short score, at 63.3, has been elevated all month and remains well above neutral. Yet borrow costs tell a calmer story. Cost to borrow is just 0.45% annually — cheap even after a 59% weekly rise, which was itself a recovery from an anomalously low mid-April dip. Availability is not yet tight; the lending pool still has room. The picture is one of growing conviction among short sellers, but no squeeze mechanics yet.
The options market is reading the same situation very differently. The put/call ratio has collapsed to 0.33 — nearly 1.8 standard deviations below its 20-day average of 0.47. That is among the most call-heavy readings FLO has seen, sitting close to its 52-week low of 0.26. Through all of March and into mid-April, the PCR ran comfortably above 0.5. The shift over the past two weeks is pronounced: options traders have pivoted from defensive hedging to outright bullish positioning ahead of the earnings date. Short sellers and options traders are pointing in opposite directions, and that tension is the defining setup for next month's print.
The Street is uniformly cautious, which may partly explain the elevated short interest. Recent analyst moves have been one-directional. BNP Paribas cut its target to $8 in early April — right at current levels — while maintaining an Underperform. Deutsche Bank trimmed to $7, also keeping a Hold. Both moves followed a string of target reductions stretching back through 2025. The consensus mean price target is $10, implying roughly 13% upside from the $8.87 close — but that figure sits at odds with BNP's $8 floor, and with Deutsche Bank's $7. The direction of analyst travel is clearly downward. On valuation, the PE has expanded to 10.6x over the past month, up nearly a full turn in 30 days, as the stock has recovered 5.6% in a month from lows. The EV/EBITDA is 8.3x — modest for the sector, which accounts for some of the options community's relative optimism. The forward yield, at 9.6%, is the standout value argument: the dividend score ranks at the 100th percentile, meaning FLO's income credentials are near-unmatched in the universe. However, the dividend history in the data is stale, with the most recent entries from 2022, so investors should verify current payment status independently.
The CEO's recent activity adds a note of caution. Chairman and CEO Ryals McMullian sold 209,000 shares on April 1 at $8.03 per share — raising $1.68 million — just as the stock was trading near multi-year lows. That transaction carries a significance score of 3 out of 10, modest but worth noting given the timing. The net insider position over 90 days is technically positive at $2.6 million, but that figure is inflated by non-cash award entries in February. The net cash flow from actual sales is negative. Institutional holders are stable; Vanguard holds 9.9% and BlackRock 9.8%, both with modestly increased positions as of March 31. State Street added nearly 1.9 million shares in the same period. The passive accumulation contrasts with the CEO's sale.
The earnings history sharpens the risk picture. FLO fell 14.9% the day after its February 13 report and extended that to an 11.3% loss over five days. The March 12 print produced a modest 2% bounce on day one, but a 2.9% reversal by day five. The asymmetry is notable: big downside moves, limited upside recovery. With short sellers adding aggressively into the May 14 report, and the stock still down 17.7% year-to-date despite its recent bounce, the interplay between an elevated short position, a call-heavy options skew, and a track record of sharp post-earnings drops is the central tension to watch as the date approaches.
See the live data behind this article on ORTEX.
Open FLO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
